Drug Shortage Report for PMS-CIPROFLOXACIN XL
Report ID | 194525 |
Drug Identification Number | 02416433 |
Brand name | PMS-CIPROFLOXACIN XL |
Common or Proper name | CIPROFLOXACIN XL |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | CIPROFLOXACIN |
Strength(s) | 500MG |
Dosage form(s) | TABLET (IMMEDIATE AND EXTENDED RELEASE) TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | J01MA |
ATC description | QUINOLONE ANTIBACTERIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2023-07-17 |
Actual start date | |
Estimated end date | 2025-12-31 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2025-01-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v20 | 2025-01-07 | French | Compare |
v19 | 2025-01-07 | English | Compare |
v18 | 2024-07-10 | French | Compare |
v17 | 2024-07-10 | English | Compare |
v16 | 2024-05-10 | French | Compare |
v15 | 2024-05-10 | English | Compare |
v14 | 2024-05-10 | English | Compare |
v13 | 2024-04-29 | French | Compare |
v12 | 2024-04-29 | English | Compare |
v11 | 2024-03-15 | French | Compare |
v10 | 2024-03-15 | English | Compare |
v9 | 2023-12-27 | French | Compare |
v8 | 2023-12-27 | English | Compare |
v7 | 2023-09-18 | French | Compare |
v6 | 2023-09-18 | English | Compare |
v5 | 2023-07-18 | English | Compare |
v4 | 2023-06-26 | French | Compare |
v3 | 2023-06-26 | English | Compare |
v2 | 2023-06-09 | French | Compare |
v1 | 2023-06-09 | English | Compare |
Showing 1 to 20 of 20